Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-87.1%Return on Equity
VS
Market
Sector
Industry
History
$ 2.19Close
$ 1.95 - $ 5.35 52-Week Range
Ticker Information
Ticker
CRDFCompany Name
CARDIFF ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCARDIFF ONCOLOGY INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CRDF - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 58.61M | $ -51.04M | -87.1% |
| 3/31/2025 | $ 70.88M | $ -48.88M | -68.96% |
| 12/31/2024 | $ 82.95M | $ -45.45M | -54.8% |
| 9/30/2024 | $ 49.39M | $ -43.01M | -87.07% |
| 6/30/2024 | $ 52.39M | $ -40.88M | -78.04% |
| 3/31/2024 | $ 60.89M | $ -40.25M | -66.1% |
| 12/31/2023 | $ 69.74M | $ -41.47M | -59.46% |
| 9/30/2023 | $ 77.83M | $ -40.83M | -52.46% |
| 6/30/2023 | $ 86.58M | $ -39.66M | -45.81% |
| 3/31/2023 | $ 96.5M | $ -38.96M | -40.37% |
Key Performance Insights, Last 5 Years
- CARDIFF ONCOLOGY INC's latest trailing twelve months (TTM) ROE stands at -60.39%.
- Over the past 5 years, CARDIFF ONCOLOGY INC's average ROE has been -46.09%.
- The median ROE for CARDIFF ONCOLOGY INC during this period was -43.09%
- CARDIFF ONCOLOGY INC reached its highest ROE over the past 5 years at -16.6%.
- The lowest ROE recorded by CARDIFF ONCOLOGY INC in the same timeframe -87.1%
CARDIFF ONCOLOGY INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for CARDIFF ONCOLOGY INC is calculated as follows: Net Inc. Cmn. [ $ -20.24M ] / Equity [ $ 33.52M ]
(=) ROE [ -60.39% ] CRDF - Return on Equity, Last 5 years
-87.1%
Minimum
Jun 30, 2025
-16.6%
Maximum
Jun 30, 2021
-46.09%
Average
-43.09%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |